Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin C Conklin

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Antimicrobial Agents and Chemotherapy|January 16, 2013
N152G, -S, and -T substitutions in CMY-2 β-lactamase increase catalytic efficiency for cefoxitin and inactivation rates for tazobactamMarion J Skalweit, Mei Li, Benjamin C Conklin, et al.
Antimicrobial Agents and Chemotherapy|August 22, 2012
Substitutions at position 105 in SHV family β-lactamases decrease catalytic efficiency and cause inhibitor resistanceMei Li, Benjamin C Conklin, Magdalena A Taracila, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Antimicrobial Agents and Chemotherapy|January 16, 2013
N152G, -S, and -T substitutions in CMY-2 β-lactamase increase catalytic efficiency for cefoxitin and inactivation rates for tazobactamMarion J Skalweit, Mei Li, Benjamin C Conklin, et al.
Antimicrobial Agents and Chemotherapy|August 22, 2012
Substitutions at position 105 in SHV family β-lactamases decrease catalytic efficiency and cause inhibitor resistanceMei Li, Benjamin C Conklin, Magdalena A Taracila, et al.
Pageof 1